Evaluation of a New Coating in Cement Less Femoral Stems
No Mid-term Advantage by Electrochemical Deposition of Hydroxyl-apatite in Cementless Femoral Stems. 5-year RSA and DXA Results From a Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- non-inflammatory hip arthritis, life expectancy of at least 10 years and hip anatomy allowing the use of standard implants
Exclusion Criteria:
- infection, revision surgery, severe morbidity and obvious bone loss
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Bonemaster
Cement-less femoral stems with electrochemical deposition of hydroxyapatite
|
Femoral stem with electrochemical deposition of hydroxyapatite
|
|
Active Comparator: Hydroxyapatite
Cement-less femoral stems with plasmasprayed hydroxyapatite
|
Femoral stem with electrochemical deposition of hydroxyapatite
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Early and intermediate periprosthetic bone remodeling
Time Frame: 5 years
|
Bone densitometry measured by DXA
|
5 years
|
|
Early and intermediate femoral stem stability
Time Frame: 5 years
|
Radiostereometric analysis of femoral stem movements relative to bone
|
5 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical function
Time Frame: 5 years
|
Hip questionares, Harris Hip Score and Oxford Hip Score
|
5 years
|
|
Radiographic signs of loosening
Time Frame: 5 years
|
Conventional x-ray
|
5 years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ORTHO.CR.GH30.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.